Annals of Hematology

Supplementary Table S1: Summary of therapies in drug class groups.

Drug Class Groups / Therapies
Chemotherapy / ACVBP, AD+C, BACOP, bendamustine, CdM, CEEP, CEOP, CHEOP, chlorambucil, CHOP, CHOP/CVP, CHVP, cisplatin, CMD, CNOP, CNOP/CVP, COMP, COP, COP-X, CVP, CyclOBEAP, cyclophosphamide, DA-EPOCH, dexamethasone, DHAP, DOCE, enzastaurin, EPOCH, FAD, FC, FCM, fludarabine, FM, FMD, FMP, FND, gemcitabine, GemOx, HCVAD, MCP, methotrexante/cytarabine, mini-CEOP, PAF, pentostatin, PEPC, pirarubicin, P-VEBEC, SHiDo, THP, VAD
Targeted Therapy / bevacizumab, bortezomib, celecoxib, cladribine, enzastaurin, epratuzumab, everolimus, flavopiridol, galiximab, ofatumumab, rituximab, SAM486A, temsirolimus, YM155
Immunotherapy / GM-CSF, lenalidomide, lFNalpha 2a, lFNalpha 2b, prednisone, thalidomide

Therapy abbreviations:

ACVBP - doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone, intrathecal methotrexate for first four cycles

AD + C - doxorubicin, dexamethasone, and chlorambucil

BACOP - cyclophosphamide, epidoxorubicin, vincristine, bleomycin, and prednisone

CdM - cladribine and mitoxantrone

CEEP - cyclophosphamide, epirubicin, vindesine, and prednisone

CEOP - cyclophosphamide, epirubicin, vincristine and prednisone

CHEOP - cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide

CHOP - cyclophosphamide, doxorubicin, vincristine, and prednisone

CHVP - cyclophosphamide, doxorubicin, teniposide, and prednisone

CMD - CPT-11(irinotican), mitoxantrone and dexamethasone

CNOP - cyclophosphamide, mitoxantrone, vincristine, and prednisone

COMP - cyclophosphamide, NLPD-Myocet, vincristine, and prednisone

COP - cyclophosphamide, vincristine, and prednisolone

COP-X - Daunorubicin, cyclophosphamide, vincristine, and prednisolone

CVP - cyclophosphamide, vincristine and prednisone

CyclOBEAP - Doxorubicin, cyclophosphamide, etoposide, and vincristine, bleomycin, and Prednisolone

DA-EPOCH - dose adjusted EPOCH (etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone)

DHAP - cisplatin, cytosine arabinoside and dexamethasone

DOCE - doxorubicin, epirubicin, vincristine and cyclophosphamide

EPOCH - etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone

FAD - fludarabine, adriamycin, and dexamethasone

FC - fludarabine and cyclophosphamide

FCM - fludarabine, cyclophosphamide, and mitoxantrone

FM - Fludarabine and mitoxantrone

FMD - fludarabine, adriamycin, and dexamethasone

FMP - fludarabine, mitoxantrone, and prednisone

FND - fludarabine, mitoxantrone, and dexamethasone

GeMOX - gemcitabine and oxiplatin

GM –CSF - granulocyte macrophage colony stimulating factor

HCVAD - hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, and dexamethasone)

MCP - mitoxantrone, chlorambucil, and prednisolone

Mini-CEOP - low-dose cyclophosphamide, epirubicin, vincristine and prednisone

PAF - cisplatin, fludarabine, and ara-C

PEPC - prednisone, etoposide, procarbazine and cyclophosphamide

P-VEBEC - epirubicin, cyclophosphamide, etoposide, vinblastine, bleomycin and prednisone

SHiDo - sequential high dose chemotherapy

THP - pirarubicin

VAD - vincristine, doxorubicine, and dexamethasone